Osteolysis in transforaminal lumbar interbody fusion with bone morphogenetic protein-2

Spine

Volumn 36, Issue 8, 2011, Pages 672-676

  Knox, Cpt Jeffrey B ^a   Dai, Cpt Joseph M ^a   Orchowski, Ltc Joseph ^a  

^a TRIPLER ARMY MEDICAL CENTER   (United States)

Author keywords

BMP; complication; interbody fusion; osteobiologics; osteolysis

Indexed keywords

RECOMBINANT BONE MORPHOGENETIC PROTEIN 2;

ADULT; ARTICLE; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; FEMALE; FOLLOW UP; GRAFT DYSFUNCTION; GRAFT SUBSIDENCE; HUMAN; INTERVERTEBRAL CAGE MIGRATION; MAJOR CLINICAL STUDY; MALE; OSTEOLYSIS; POSTOPERATIVE PERIOD; PRIORITY JOURNAL; RETROSPECTIVE STUDY; RISK ASSESSMENT; SPINE FUSION; SPINE RADIOGRAPHY; TRANSFORAMINAL LUMBAR INTERBODY FUSION;

ADULT; BONE MORPHOGENETIC PROTEIN 2; FEMALE; FOLLOW-UP STUDIES; HUMANS; LUMBAR VERTEBRAE; MALE; MIDDLE AGED; OSTEOLYSIS; POSTOPERATIVE COMPLICATIONS; RISK ASSESSMENT; RISK FACTORS; SPINAL FUSION; TIME FACTORS; TOMOGRAPHY, X-RAY COMPUTED; YOUNG ADULT;

EID: 79955057396     PISSN: 03622436     EISSN: 15281159     Source Type: Journal    
DOI: 10.1097/BRS.0b013e3181e030e0     Document Type: Article

References (35)

1. Harms J, Rolinger H. A one-stage procedure in operative treatment of spondylolisthesis: dorsal traction-reposition and anterior fusion [in German]. Z Orthop Ihre Grenzgeb 1982;120:343-7. (Pubitemid 12098700)
2. Dhall SS, Wang MY, Mummaneni PV. Clinical and radiographic comparison of mini-open transforaminal lumbar interbody fusion with open transforaminal lumbar interbody fusion in 42 patients with long-term follow-up. J Neurosurg Spine 2008;9:560-5.
3. Goyal N, Wimberley DW, Hyatt A, et al. Radiographic and clinical outcomes after instrumented reduction and transforaminal lumbar interbody fusion of mid and high-grade isthmic spondylolisthesis. J Spinal Disord Tech 2009;22:321-7.
4. Kim JS, Kang BU, Lee SH, et al. Mini-transforaminal lumbar interbody fusion versus anterior lumbar interbody fusion augmented by percutaneous pedicle screw fi xation: a comparison of surgical outcomes in adult low-grade isthmic spondylolisthesis. J Spinal Disord Tech 2009;22:114-21.
5. Peng CW, Yue WM, Poh SY, et al. Clinical and radiological outcomes of minimally invasive versus open transforaminal lumbar interbody fusion. Spine (Phila Pa 1976) 2009;34:1385-9.
6. Potter BK, Freedman BA, Verwiebe EG, et al. Transforaminal lumbar interbody fusion: clinical and radiographic results and complications in 100 consecutive patients. J Spinal Disord Tech 2005;18:337-46. (Pubitemid 44378151)
7. Rosenberg WS, Mummaneni PV. Transforaminal lumbar interbody fusion: technique, complications, and early results. Neurosurgery 2001;48:569-74; discussion 74-5.
8. Rihn JA, Patel R, Makda J, et al. Complications associated with single-level transforaminal lumbar interbody fusion. Spine J 2009; 9:623-9.
9. Rivet DJ, Jeck D, Brennan J, et al. Clinical outcomes and complications associated with pedicle screw fi xation-augmented lumbar interbody fusion. J Neurosurg Spine 2004;1:261-6.
10. Dawson E, Bae HW, Burkus JK, et al. Recombinant human bone morphogenetic protein-2 on an absorbable collagen sponge with an osteoconductive bulking agent in posterolateral arthrodesis with instrumentation. A prospective randomized trial. J Bone Joint Surg Am 2009;91:1604-13.
11. Ahlmann E, Patzakis M, Roidis N, et al. Comparison of anterior and posterior iliac crest bone grafts in terms of harvest-site morbidity and functional outcomes. J Bone Joint Surg Am 2002; 84-A:716-20.
12. Robertson PA, Wray AC. Natural history of posterior iliac crest bone graft donation for spinal surgery: a prospective analysis of morbidity. Spine (Phila Pa 1976) 2001;26:1473-6. (Pubitemid 32606820)
13. Schwartz CE, Martha JF, Kowalski P, et al. Prospective evaluation of chronic pain associated with posterior autologous iliac crest bone graft harvest and its effect on postoperative outcome. Health Qual Life Outcomes 2009;7:49.
14. Hu RW, Bohlman HH. Fracture at the iliac bone graft harvest site after fusion of the spine. Clin Orthop Relat Res 1994:309:208-13.
15. Chan K, Resnick D, Pathria M, et al. Pelvic instability after bone graft harvesting from posterior iliac crest: report of nine patients. Skeletal Radiol 2001;30:278-81. (Pubitemid 32471934)
16. Lim EV, Lavadia WT, Roberts JM. Superior gluteal artery injury during iliac bone grafting for spinal fusion. A case report and literature review. Spine (Phila Pa 1976) 1996;21:2376-8. (Pubitemid 26362122)
17. Kingsley DM. The TGF-beta superfamily: new members, new receptors, and new genetic tests of function in different organisms. Genes Dev 1994;8:133-46.
18. Cahill KS, Chi JH, Day A, et al. Prevalence, complications, and hospital charges associated with use of bone-morphogenetic proteins in spinal fusion procedures. JAMA 2009;302:58-66.
19. Singh K, Smucker JD, Gill S, et al. Use of recombinant human bone morphogenetic protein-2 as an adjunct in posterolateral lumbar spine fusion: a prospective CT-scan analysis at one and two years. J Spinal Disord Tech 2006;19:416-23. (Pubitemid 44197593)
20. Boden SD, Kang J, Sandhu H, et al. Use of recombinant human bone morphogenetic protein-2 to achieve posterolateral lumbar spine fusion in humans: a prospective, randomized clinical pilot trial: 2002 Volvo Award in clinical studies. Spine (Phila Pa 1976) 2002;27:2662-73. (Pubitemid 35425320)
21. Glassman SD, Dimar JR, Carreon LY, et al. Initial fusion rates with recombinant human bone morphogenetic protein-2/compression resistant matrix and a hydroxyapatite and tricalcium phosphate/ collagen carrier in posterolateral spinal fusion. Spine (Phila Pa 1976) 2005;30:1694-8. (Pubitemid 41099480)
22. Dimar JR, Glassman SD, Burkus KJ, et al. Clinical outcomes and fusion success at 2 years of single-level instrumented posterolateral fusions with recombinant human bone morphogenetic protein-2/ compression resistant matrix versus iliac crest bone graft. Spine (Phila Pa 1976) 2006;31:2534-9; discussion 40.
23. Slosar PJ, Josey R, Reynolds J. Accelerating lumbar fusions by combining rhBMP-2 with allograft bone: a prospective analysis of interbody fusion rates and clinical outcomes. Spine J 2007;7:301-7. (Pubitemid 46667736)
24. Dimar JR II, Glassman SD, Burkus JK, et al. Clinical and radiographic analysis of an optimized rhBMP-2 formulation as an autograft replacement in posterolateral lumbar spine arthrodesis. J Bone Joint Surg Am 2009;91:1377-86.
25. Mindea SA, Shih P, Song JK. Recombinant human bone morphogenetic protein-2-induced radiculitis in elective minimally invasive transforaminal lumbar interbody fusions: a series review. Spine (Phila Pa 1976) 2009;34:1480-4; discussion 5.
26. Joseph V, Rampersaud YR. Heterotopic bone formation with the use of rhBMP2 in posterior minimal access interbody fusion: a CT analysis. Spine (Phila Pa 1976) 2007;32:2885-90. (Pubitemid 351339361)
27. Wong DA, Kumar A, Jatana S, et al. Neurologic impairment from ectopic bone in the lumbar canal: a potential complication of offlabel PLIF/TLIF use of bone morphogenetic protein-2 (BMP-2). Spine J 2008;8:1011-8.
28. Lewandrowski KU, Nanson C, Calderon R. Vertebral osteolysis after posterior interbody lumbar fusion with recombinant human bone morphogenetic protein 2: a report of fi ve cases. Spine J 2007;7:609-14. (Pubitemid 47471438)
29. McClellan JW, Mulconrey DS, Forbes RJ, et al. Vertebral bone resorption after transforaminal lumbar interbody fusion with bone morphogenetic protein (rhBMP-2). J Spinal Disord Tech 2006;19:483-6. (Pubitemid 44526745)
30. Vaidya R, Weir R, Sethi A, et al. Interbody fusion with allograft and rhBMP-2 leads to consistent fusion but early subsidence. J Bone Joint Surg Br 2007;89:342-5. (Pubitemid 46563910)
31. Vaidya R, Sethi A, Bartol S, et al. Complications in the use of rh- BMP-2 in PEEK cages for interbody spinal fusions. J Spinal Disord Tech 2008;21:557-62.
32. Meisel HJ, Schnoring M, Hohaus C, et al. Posterior lumbar interbody fusion using rhBMP-2. Eur Spine J 2008;17:1735-44.
33. Itoh K, Udagawa N, Katagiri T, et al. Bone morphogenetic protein 2 stimulates osteoclast differentiation and survival supported by receptor activator of nuclear factor-kappaB ligand. Endocrinology 2001;142:3656-62. (Pubitemid 32681777)
34. Otsuka ENM, Hagiwara H. Treatment of myoblastic C2C12 cells with BMP-2 stimulates vitamin D-induced formation of osteoclasts. Calcif Tissue Int 2003;73:72-7. (Pubitemid 37022082)
35. Poynton AR, Lane JM. Safety profi le for the clinical use of bone morphogenetic proteins in the spine. Spine (Phila Pa 1976) 2002;27:S40-8.